These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31959423)

  • 1. Development and optimization of OspC chimeritope vaccinogens for Lyme disease.
    Izac JR; O'Bier NS; Oliver LD; Camire AC; Earnhart CG; LeBlanc Rhodes DV; Young BF; Parnham SR; Davies C; Marconi RT
    Vaccine; 2020 Feb; 38(8):1915-1924. PubMed ID: 31959423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of antibody responses to outer surface protein (Osp)A and OspC in dogs vaccinated with Lyme disease vaccines.
    Camire AC; Hatke AL; King VL; Millership J; Ritter DM; Sobell N; Weber A; Marconi RT
    Vet J; 2021 Jul; 273():105676. PubMed ID: 34148599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
    Izac JR; Oliver LD; Earnhart CG; Marconi RT
    Vaccine; 2017 May; 35(24):3178-3185. PubMed ID: 28479174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.
    Izac JR; Camire AC; Earnhart CG; Embers ME; Funk RA; Breitschwerdt EB; Marconi RT
    Vaccine; 2019 Apr; 37(17):2401-2407. PubMed ID: 30922701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences.
    Earnhart CG; Marconi RT
    Hum Vaccin; 2007; 3(6):281-9. PubMed ID: 17921702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.
    Oliver LD; Earnhart CG; Virginia-Rhodes D; Theisen M; Marconi RT
    Vet J; 2016 Dec; 218():27-33. PubMed ID: 27938705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
    LaFleur RL; Dant JC; Wasmoen TL; Callister SM; Jobe DA; Lovrich SD; Warner TF; Abdelmagid O; Schell RF
    Clin Vaccine Immunol; 2009 Feb; 16(2):253-9. PubMed ID: 19052162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Elucidation of a Protective B Cell Epitope on Outer Surface Protein C (OspC) of the Lyme Disease Spirochete, Borreliella burgdorferi.
    Rudolph MJ; Davis SA; Haque HME; Weis DD; Vance DJ; Piazza CL; Ejemel M; Cavacini L; Wang Y; Mbow ML; Gilmore RD; Mantis NJ
    mBio; 2023 Apr; 14(2):e0298122. PubMed ID: 36976016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tick-Tattoo: DNA Vaccination Against
    Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
    Front Immunol; 2021; 12():615011. PubMed ID: 33717102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody profiling of a Borreliella burgdorferi (Lyme disease) C6 antibody positive, symptomatic Rottweiler and her pups.
    Hatke AL; Green DR; Stasiak K; Marconi RT
    Vet J; 2020 Aug; 262():105504. PubMed ID: 32792093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains.
    Earnhart CG; Buckles EL; Marconi RT
    Vaccine; 2007 Jan; 25(3):466-80. PubMed ID: 16996663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.
    Earnhart CG; Marconi RT
    Vaccine; 2007 Apr; 25(17):3419-27. PubMed ID: 17239505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FtlA and FtlB Are Candidates for Inclusion in a Next-Generation Multiantigen Subunit Vaccine for Lyme Disease.
    Camire AC; O'Bier NS; Patel DT; Cramer NA; Straubinger RK; Breitschwerdt EB; Funk RA; Marconi RT
    Infect Immun; 2022 Oct; 90(10):e0036422. PubMed ID: 36102656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
    Lovrich SD; Jobe DA; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.
    Buckles EL; Earnhart CG; Marconi RT
    Clin Vaccine Immunol; 2006 Oct; 13(10):1162-5. PubMed ID: 17028218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of B-cell epitopes of Borrelia burgdorferi outer surface protein C by screening a phage-displayed gene fragment library.
    Pulzova L; Flachbartova Z; Bencurova E; Potocnakova L; Comor L; Schreterova E; Bhide M
    Microbiol Immunol; 2016 Oct; 60(10):669-677. PubMed ID: 27619624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.
    Edmondson DG; Prabhakaran S; Norris SJ; Ullmann AJ; Piesman J; Dolan M; Probst C; Radzimski C; Stöcker W; Komorowski L
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27733423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferi.
    Baum E; Randall AZ; Zeller M; Barbour AG
    PLoS One; 2013; 8(6):e67445. PubMed ID: 23826301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VANGUARD®crLyme: A next generation Lyme disease vaccine that prevents
    Marconi RT; Garcia-Tapia D; Hoevers J; Honsberger N; King VL; Ritter D; Schwahn DJ; Swearingin L; Weber A; Winkler MTC; Millership J
    Vaccine X; 2020 Dec; 6():100079. PubMed ID: 33336185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.